Transcatheter Mitral Valve Replacement: A Need for Better Patient Selection
- PMID: 34736562
- DOI: 10.1016/j.jacc.2021.08.062
Transcatheter Mitral Valve Replacement: A Need for Better Patient Selection
Keywords: heart failure; mitral regurgitation; mitral valve prosthesis; prognosis; transcatheter mitral valve replacement.
Conflict of interest statement
Funding Support and Author Disclosures Dr Rodés-Cabau has received institutional research grants from Edwards Lifesciences and Medtronic; and holds the Research Chair ”Fondation Famille Jacques Larivière” for the Development of Structural Heart Disease Interventions. Dr Mack has served as the co-principal investigator or study chair for clinical trials sponsored by Abbott, Edwards Lifesciences, and Medtronic. Dr Regueiro has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.J Am Coll Cardiol. 2021 Nov 9;78(19):1847-1859. doi: 10.1016/j.jacc.2021.08.060. J Am Coll Cardiol. 2021. PMID: 34736561 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources